Mariano Barbacid’s Study on Pancreatic Cancer Is Withdrawn Due to Conflict of Interest
24 Articles
24 Articles
The organization withdraws the work in the magazine PNAS and reproaches that the scientist and two colleagues did not declare that they own part of the company Vega Oncotargets for the commercial exploitation of the results
The organization withdraws the work in the magazine PNAS and reproaches that the scientist and two colleagues did not declare that they own part of the company Vega Oncotargets for the commercial exploitation of the results
The National Academy of Sciences of the United States withdrew a study on pancreatic cancer led by the Spanish scientist Mariano Barbacid, after detecting ethical irregularities related to undeclared economic interests. Mariano Barbacid's work, which had generated great expectations for proposing a possible “cura” in animal models of pancreatic cancer, was published in the scientific journal PNAS and pointed out that an experimental therapy mana…
The scientific publication withdraws the article for omitting a financial conflict of interest linked to a commercial operator.
The U.S. Academy of Sciences has decided to remove from its scientific journal (PNAS) the article they had published from a group of researchers, including the Spanish Mariano Barbacid, on progress in combating pancreatic cancer, by detecting a “relevant” conflict of interest.Continue reading...
This Monday, the magazine 'PNAS ', published by the National Academy of Sciences of the United States, has taken the decision to withdraw the study led by Mariano Barbacid on a promising triple therapy against pancreatic cancer , published last January. The reason for this retraction does not respond to failures in experimental data nor questions the validity of the finding, is due to the fact that the veteran oncologist and former director of t…
Coverage Details
Bias Distribution
- 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
